The New York Times
As Japan races to avoid a nuclear disaster, some Americans and companies
in the United States are scrambling to obtain potassium iodide, a drug
that can protect people from radiation-induced .
“We’ve sold more in the past three days than we have in the past three
years,” said Jim Small, president of the American arm of Recipharm, a
Swedish company that is a major supplier of potassium iodide... Read More